385 related articles for article (PubMed ID: 33451143)
1. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection.
El-Mowafy M; Elgaml A; El-Mesery M; Sultan S; Ahmed TAE; Gomaa AI; Aly M; Mottawea W
Biology (Basel); 2021 Jan; 10(1):. PubMed ID: 33451143
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the Treatment-Naive Gut Microbiome in Newly Diagnosed Hepatitis C Virus Infection.
Sultan S; El-Mowafy M; Elgaml A; El-Mesery M; El Shabrawi A; Elegezy M; Hammami R; Mottawea W
ACS Infect Dis; 2021 May; 7(5):1059-1068. PubMed ID: 33119247
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Microbiota Gut-Liver Axis during HCV Chronic Infection: A Schematic Overview.
Marascio N; De Caro C; Quirino A; Mazzitelli M; Russo E; Torti C; Matera G
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233804
[TBL] [Abstract][Full Text] [Related]
5. Microbiota and viral hepatitis: State of the art of a complex matter.
Milosevic I; Russo E; Vujovic A; Barac A; Stevanovic O; Gitto S; Amedei A
World J Gastroenterol; 2021 Sep; 27(33):5488-5501. PubMed ID: 34588747
[TBL] [Abstract][Full Text] [Related]
6. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis.
Ponziani FR; Putignani L; Paroni Sterbini F; Petito V; Picca A; Del Chierico F; Reddel S; Calvani R; Marzetti E; Sanguinetti M; Gasbarrini A; Pompili M
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1301-1311. PubMed ID: 30345704
[TBL] [Abstract][Full Text] [Related]
7. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
8. Gut Dysbiosis Associated With Hepatitis C Virus Infection.
Inoue T; Nakayama J; Moriya K; Kawaratani H; Momoda R; Ito K; Iio E; Nojiri S; Fujiwara K; Yoneda M; Yoshiji H; Tanaka Y
Clin Infect Dis; 2018 Aug; 67(6):869-877. PubMed ID: 29718124
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients.
Pérez-Matute P; Íñiguez M; Villanueva-Millán MJ; Recio-Fernández E; Vázquez AM; Sánchez SC; Morano LE; Oteo JA
Eur J Intern Med; 2019 Sep; 67():47-58. PubMed ID: 31221551
[TBL] [Abstract][Full Text] [Related]
10. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
11. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection.
Sun X; Pan CQ; Xing H
Hepatol Int; 2021 Oct; 15(5):1053-1067. PubMed ID: 34596865
[TBL] [Abstract][Full Text] [Related]
12. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.
Bajaj JS; Sterling RK; Betrapally NS; Nixon DE; Fuchs M; Daita K; Heuman DM; Sikaroodi M; Hylemon PB; White MB; Ganapathy D; Gillevet PM
Aliment Pharmacol Ther; 2016 Sep; 44(6):638-43. PubMed ID: 27417456
[TBL] [Abstract][Full Text] [Related]
13. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
14. The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases.
Kanmani P; Suganya K; Kim H
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33207562
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
16. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis.
Neag MA; Mitre AO; Catinean A; Buzoianu AD
World J Gastroenterol; 2021 Nov; 27(43):7446-7461. PubMed ID: 34887642
[TBL] [Abstract][Full Text] [Related]
17. Targeting Microbiota: What Do We Know about It at Present?
Derovs A; Laivacuma S; Krumina A
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31405111
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives.
Paratore M; Santopaolo F; Cammarota G; Pompili M; Gasbarrini A; Ponziani FR
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204748
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
